Circadian clock molecule REV-ERBα regulates lung fibrotic progression through collagen stabilization.

Wang, Qixin, Isaac Kirubakaran Sundar, Joseph H Lucas, Jun-Gyu Park, Aitor Nogales, Luis Martinez-Sobrido, and Irfan Rahman. 2023. “Circadian Clock Molecule REV-ERBα Regulates Lung Fibrotic Progression through Collagen Stabilization.”. Nature Communications 14 (1): 1295.

Abstract

Molecular clock REV-ERBα is central to regulating lung injuries, and decreased REV-ERBα abundance mediates sensitivity to pro-fibrotic insults and exacerbates fibrotic progression. In this study, we determine the role of REV-ERBα in fibrogenesis induced by bleomycin and Influenza A virus (IAV). Bleomycin exposure decreases the abundance of REV-ERBα, and mice dosed with bleomycin at night display exacerbated lung fibrogenesis. Rev-erbα agonist (SR9009) treatment prevents bleomycin induced collagen overexpression in mice. Rev-erbα global heterozygous (Rev-erbα Het) mice infected with IAV showed augmented levels of collagens and lysyl oxidases compared with WT-infected mice. Furthermore, Rev-erbα agonist (GSK4112) prevents collagen and lysyl oxidase overexpression induced by TGFβ in human lung fibroblasts, whereas the Rev-erbα antagonist exacerbates it. Overall, these results indicate that loss of REV-ERBα exacerbates the fibrotic responses by promoting collagen and lysyl oxidase expression, whereas Rev-erbα agonist prevents it. This study provides the potential of Rev-erbα agonists in the treatment of pulmonary fibrosis.

Last updated on 04/14/2023
PubMed